Bristol-Myers Squibb Co. share price logo

Bristol-Myers Squibb Co.

NASDAQ: BMY

Large Cap

$54.00

-1.28

(-2.32%)

as on

Bristol-Myers Squibb Co. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $53.44
    $55.33
    downward going graph

    1.04%

    Downside

    2.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $42.52
    $62.89
    downward going graph

    21.26%

    Downside

    16.46%

    Upside

    downward going graph

Bristol-Myers Squibb Co. share price movements today

Previous Close
$55.28
Open
$55.24
Volume
11.6M
Day's Low - High
$53.44 - $55.33
52 Week Low - High
$42.52 - $62.89

Bristol-Myers Squibb Co. Historical Returns

1 Month Return
-7.39 %
3 Month Return
-7.07 %
1 Year Return
+ 15.29 %
3 Year Return
-18.38 %
5 Year Return
-18.76 %

Bristol-Myers Squibb Co. Stock Fundamentals & Key Indicators

Check Bristol-Myers Squibb Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$112.9B

EPS (TTM)

6.3104

Dividend Yield

4.47%

Quarterly Earnings Growth YOY

0.09%

PE Ratio (TTM)

15.48

Industry PE ratio

11.283076923076923

PEG Ratio

177.2425

EBITDA

19.0B

Revenue (TTM)

48.5B

Profit Margin

15.01%

Return On Equity TTM

38.73%

Bristol-Myers Squibb Co. Stock Valuation

Track how Bristol-Myers Squibb Co. P/E has moved over time to understand its valuation trends.

Bristol-Myers Squibb Co. in the last 5 years

  • Overview

  • Trends

Lowest (7.12x)

September 30, 2025

Industry (11.28x)

June 19, 2026

Today (15.48x)

June 19, 2026

Highest (49.01x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 15.48x

Bristol-Myers Squibb Co. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bristol-Myers Squibb Co. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bristol-Myers Squibb Co. image
Bristol-Myers Squibb Co.
HOLD$112.9B-18.76%15.4815.01%4.47%
Eli Lilly & Co. image
Eli Lilly & Co.
BUY$991.6B402.66%39.4734.99%0.5599999999999999%
AstraZeneca PLC image
AstraZeneca PLC
BUY$271.4B199.69%26.3217.19%1.7999999999999998%
ABBVIE INC. image
ABBVIE INC.
BUY$390.9B91.38%107.925.79%3.0300000000000002%
Johnson & Johnson image
Johnson & Johnson
BUY$563.8B41%27.1421.83%2.21%
See all

Stock Returns calculator for Bristol-Myers Squibb Co. Stock including INR - Dollar returns

The Bristol-Myers Squibb Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bristol-Myers Squibb Co. investment value today

Current value as on today

₹1,25,202

Returns

₹25,202

(+25.2%)

Returns from Bristol-Myers Squibb Co. Stock

₹15,286 (+15.29%)

Dollar Impact

₹9,916 (+9.92%)

Analyst Recommendation on Bristol-Myers Squibb Co. Stock

Based on 31 analysts

HOLD

32.26%

Buy

64.52%

Hold

3.23%

Sell

Based on 31 analysts, 64.52% of analysts recommend a 'HOLD' rating for Bristol-Myers Squibb Co.. Average target price of $63.08

Bristol-Myers Squibb Co. Share Price Target

Get share price movements and forecasts by analysts on Bristol-Myers Squibb Co..

What analysts predicted

14.39%UPSIDE

Target Price

$63.08

Current Price

$54

Analyzed by

31 Analysts

Target

$63.08

Bristol-Myers Squibb Co. target price $63.08, a slight upside of 14.39% compared to current price of $54. According to 31 analysts rating.

Indian Investors' Interest in Bristol-Myers Squibb Co. Stock

Search interest for Bristol-Myers Squibb Co. Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:21% versus previous 30 day period

Bristol-Myers Squibb Co. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
11,477
11,865
12,201
11,892
12,342
11,201
12,269
12,222
12,502
11,489
Gross Profit
6,492
6,590
6,801
6,617
7,424
7,340
8,070
8,787
8,405
8,068
Operating Income
1,952
1,535
2,584
2,288
2,531
3,521
4,117
3,639
1,419
3,271
EBITDA
4,454
-8,559
4,403
4,773
2,551
4,477
3,287
4,587
2,194
3,677
Interest Expense
316
425
521
505
496
494
485
480
51
411
Depreciation
2,464
2,532
2,596
2,592
1,880
1,012
1,011
1,011
977
594
Income Before Tax
1,674
-11,516
1,286
1,676
175
2,971
1,773
3,114
1,470
3,240
Income Tax Expense
-88
392
-398
461
99
509
460
919
384
561
Net Income
1,762
-11,911
1,680
1,211
72
2,456
1,310
2,201
1,086
2,678
Net Profit Margin
15.35%
-100.39%
13.77%
10.18%
0.58%
21.93%
10.68%
18.01%
8.69%
23.31%

Bristol-Myers Squibb Co. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
19,427
20,776
22,561
26,145
42,518
46,385
46,159
45,006
48,300
48,194
Gross Profit
14,495
14,958
16,075
17,250
21,700
26,761
26,490
25,357
27,432
32,602
Operating Income
5,179
5,239
6,394
6,439
4,492
9,540
9,271
8,472
9,658
12,696
EBITDA
6,464
6,116
6,788
7,377
4,929
20,118
19,221
19,366
3,168
14,545
Interest Expense
167
196
183
656
1,420
1,334
1,232
1,166
1,947
1,510
Depreciation
-
789
637
1,746
10,380
10,023
9,595
9,817
9,600
4,011
Income Before Tax
5,915
5,131
5,968
4,975
-6,871
8,098
7,713
8,440
-8,379
9,328
Income Tax Expense
1,408
4,156
1,021
1,515
2,124
1,084
1,368
400
554
2,272
Net Income
4,457
1,007
4,920
3,439
-8,995
6,994
6,327
8,025
-8,948
7,053
Net Profit Margin
22.94%
4.85%
21.81%
13.15%
-21.16%
15.08%
13.71%
17.83%
-18.53%
14.63%

Bristol-Myers Squibb Co. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-11,908
1,684
1,215
76
2,462
1,313
2,195
1,085
2,678
Operating Cash Flow
2,834
2,326
5,591
4,439
1,954
3,917
6,311
1,974
1,104
Investing Cash Flow
-19,618
-1,319
-219
-196
-499
-473
-1,702
-1,458
-131
Financing Cash Flow
14,644
-4,023
-3,852
-1,642
-993
-1,836
-1,490
-6,029
-1,560
Change in Cash
-2,185
-3,038
1,597
2,454
528
1,736
3,115
-5,508
-635

Bristol-Myers Squibb Co. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
975
4,947
3,460
-8,995
7,014
6,345
8,040
-8,933
7,055
Operating Cash Flow
5,275
7,066
8,067
14,052
16,207
13,066
13,860
15,190
14,156
Investing Cash Flow
-66
-2,000
-9,770
-10,859
-538
-1,062
-2,295
-21,352
-4,132
Financing Cash Flow
-4,077
-3,535
7,621
-1,151
-16,224
-16,962
-9,416
5,127
-10,348
Change in Cash
1,184
1,490
5,909
2,153
-657
-4,991
2,194
-1,172
-137

Mutual Funds that own Bristol-Myers Squibb Co. Stock

Check out the Mutual Funds with significant holdings in Bristol-Myers Squibb Co..

Global Institutional Holdings in Bristol-Myers Squibb Co.

Funds
Holdings
Vanguard Group Inc
9.73%
Legal & General Group PLC
0.83%
Vanguard Capital Management, LLC
6.48%
Geode Capital Management, LLC
2.71%
Pzena Investment Management, LLC
0.84%
See all

Bristol-Myers Squibb Co. News & Key Events

    Insights on Bristol-Myers Squibb Co.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Bristol-Myers Squibb Co. has shown strong profit growth over the last two quarters. Their net profit increased from $1.08 billion to $2.67 billion, which reflects an average growth of 59.5% per quarter.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, AstraZeneca PLC has given 150.1% return, outperforming this stock by 134.9%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Eli Lilly & Co. has given 136.6% return, outperforming this stock by 154.8%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Bristol-Myers Squibb Co. has experienced a decline in revenue for the past two quarters. Revenue dropped from $12.50 billion to $11.48 billion, showing an average decrease of 8.1% per quarter.

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, BMY stock has moved down by -5.5%

    About Bristol-Myers Squibb Co.

    Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. Bristol-Myers Squibb Company has a strategic collaboration with Arcus Biosciences, Inc. to develop a novel treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.
    OrganisationBristol-Myers Squibb Co.
    HeadquartersRoute 206 & Province Line Road, Princeton, NJ, United States, 08543
    IndustryDrug Manufacturers - General
    CEODr. Christopher S. Boerner Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Bristol-Myers Squibb Co.

    Name

    Title

    Mr. Charles E. Triano

    SVP & Head of Investor Relations

    Ms. Ahn Amanda Poole

    Executive VP & Chief People Officer

    Mr. Greg Meyers

    Executive VP and Chief Digital & Technology Officer

    Mr. Adam Lenkowsky

    Executive VP & Chief Commercialization Officer

    Ms. Karin Shanahan

    Executive VP, Chief Supply Chain & Operations Officer

    Ms. Cari Gallman

    Executive VP, General Counsel & Chief Policy Officer

    Dr. Joseph J. Eiden Jr.

    Head of Medical Affairs

    Dr. Christopher S. Boerner Ph.D.

    CEO & Chairman

    Mr. David V. Elkins

    Executive VP & CFO

    Mr. Cristian Massacesi M.D.

    Executive VP, Chief Medical Officer & Head of Development

    FAQs

    What is Bristol-Myers Squibb Co. share price today?

    Bristol-Myers Squibb Co. share price today is $54 as on at the close of the market. Bristol-Myers Squibb Co. share today touched a day high of $55.33 and a low of $53.44.

    What is the 52 week high and 52 week low for Bristol-Myers Squibb Co. share?

    Bristol-Myers Squibb Co. share touched a 52 week high of $62.89 on and a 52 week low of $42.52 on . Bristol-Myers Squibb Co. stock price today i.e. is closed at $54,which is 14.13% down from its 52 week high and 27.00% up from its 52 week low.

    What is Bristol-Myers Squibb Co.'s market capitalisation today?

    Bristol-Myers Squibb Co. market capitalisation is $0.11T as on .

    How to invest in Bristol-Myers Squibb Co. Stock (BMY) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Bristol-Myers Squibb Co. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bristol-Myers Squibb Co. Shares that will get you 0.0278 shares as per Bristol-Myers Squibb Co. share price of $54 per share as on June 19, 2026 at 8:45 am IST.

    What is the minimum amount required to buy Bristol-Myers Squibb Co. Stock (BMY) from India?

    Indian investors can start investing in Bristol-Myers Squibb Co. (BMY) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹943.10 in Bristol-Myers Squibb Co. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bristol-Myers Squibb Co. share’s latest price of $54 as on June 19, 2026 at 8:45 am IST, you will get 0.1852 shares of Bristol-Myers Squibb Co.. Learn more about fractional shares .

    What are the returns that Bristol-Myers Squibb Co. has given to Indian investors in the last 5 years?

    Bristol-Myers Squibb Co. stock has given -18.76% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?